COVID-19 & Rural Health Clinics

**NARHC will update this page with additional resources
throughout the COVID-19 Pandemic. You can find all Technical Assistance Webinar recordings, slides, and transcripts here.
**

HRSA Programs - RHC Funding and Resource Opportunities

Name of Grant/Allocation

Important Dates

Amount/Purpose

 Reporting Requirements & Other Links

Rural Health Clinic COVID-19 Testing and Mitigation Program

CFDA #93.697

Automatically Awarded: June 2021.

Period of Availability:
January 1, 2021 - December 31, 2022

$100,000 per RHC

To be used for COVID-19 testing, COVID-19 mitigation, and COVID-19 testing and mitigation related expenses.

Terms and Conditions
Mandatory Reporting
Webinars
NARHC FAQs

Questions? Email
RHCcovidreporting@narhc.org

HRSA COVID-19 Testing Supply Program

Ongoing -
Available Now

Direct shipments of at-home COVID-19 tests, and Point-of-Care Testing Supplies.

NARHC FAQs

NARHC TA Virtual Office Hours

HRSA RHC COVID-19 Therapeutic Treatment Program Ongoing- Available Now  Direct access to COVID-19 therapeutics Paxlovid and Lagevrio (molnupiravir). 

NARHC FAQs 

Questions? Email
RHCcovidsupplies@narhc.org

 

Rural Health Clinic Vaccine Confidence (RHCVC) Program

CFDA #93.912

Program Start Date: July 1, 2021

 

Last day to apply for No Cost Extension on EHB: May 31, 2022


Program End Date:
June 30, 2022 (last day to incur expenses)

Last day to draw down funds in PMS and complete closeout requirements: September 28, 2022

Approximately $49,500 per awarded RHC.

To improve vaccine confidence and counter vaccine hesitancy through improving education, access, etc.

HRSA Program Page

How to Draw Funds from PMS

Questions? Email
vaxconfidence@narhc.org

Electronic Handbook (EHB)

HRSA Health Grants Workshop Web Series

Payment Management System (PMS)

Vaccine Confidence Ideas from RHCs

Rural Health Clinic COVID-19 Vaccine Distribution Program


Ongoing –
Available Now

Direct shipments of the COVID-19 Vaccine (Pfizer, Moderna, and/or Johnson and Johnson).
Primary Series as well as Bivalent Doses.

Adult and pediatric COVID-19 vaccines (including those for children under 5) available.

Program Overview

CDC Vaccine Recommendations

Rural Health Clinic COVID-19 Testing Program

CFDA #93.697

Automatically Awarded beginning May 2020.

Period of Availability:
January 27, 2020 - December 31,2021

$49,461.42 Per RHC.

To be used for COVID-19 testing and COVID-19 related expenses.

Terms and Conditions
Mandatory Reporting and Program Closeout
Webinars
RHC Experiences with the COVID-19 Testing Program


Provider Relief Fund

RHCs have received multiple tranches or allocations of money from the federal government to help with COVID-19, including both general and targeted distributions from the Provider Relief Fund. It is important for RHCs to understand what funding they received, how and when it can be spent, and report on it correctly. PRF allocations can be spent on otherwise unreimbursed expenses and lost revenues related to COVID-19. PRF Reporting must be done through the PRF Reporting Portal during the time period that corresponds to the period in which an organization received funds. More information can be found here.

Please note that many RHCs and their parent organizations received funding from PRF Phase 5 and the ARP Rural allocation during periods 4 and 5 and continue to have reporting requirements in 2023.

Post-Payment Notice of Reporting Requirements issued October, 27, 2022.

 

Payment Received Period

Period of Availability

Reporting Time Period

Period 1

April 10, 2020 -

June 30, 2020

January 1, 2020 -

June 30, 2021

July 1, 2021 -

 

September 30, 2021

(Plus Extensions)

Period 2

July 1, 2020 -

December 31, 2020

January 1, 2020 -

December 31, 2021

January 1, 2022 -

 

March 31, 2022

(Plus Extensions)

Period 3

January 1, 2021 -

June 30, 2021

January 1, 2020 -

June 30, 2022

July 1, 2022 -

September 30, 2022

Period 4

July 1, 2021 -

December 31, 2021

January 1, 2020 -

December 31, 2022

January 1, 2023 -

March 31, 2023

Period 5

January 1, 2022 -

June 30, 2022

January 1, 2020 -

June 30, 2023

July 1, 2023 -

September 30, 2023

Period 6

July 1, 2022 -

December 31, 2022

January 1, 2020 - 

December 31, 2023

January 1, 2024 - 

March 31, 2024

Period 7

January 1, 2023 -

June 30, 2023

January 1, 2020 - 

June 30, 2024

July 1, 2024 - 

September 30, 2024


Public Health Emergency Duration

Many temporary waivers are in effect for the duration of the PHE. The Secretary of Health and Human Service posts their Public Health Emergency Declarations here:https://www.phe.gov/emergency/news/healthactions/phe/Pages/default.aspx. The PHE can be renewed for 3 months at a time. Commercial payers may issue their own policies with their own timelines that may or may not depend on the federal government’s declaration of a public health emergency.

**DISCLAIMER**

These resources are supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1,750,000 with 0% financed with non-governmental sources for the project period of June 2021 through May 2023. The contents are those of NARHC and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.